These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6401697)

  • 1. Elaboration of Bacillus anthracis antigens in a new, defined culture medium.
    Ristroph JD; Ivins BE
    Infect Immun; 1983 Jan; 39(1):483-6. PubMed ID: 6401697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of growth and toxin production in two vaccine strains of Bacillus anthracis.
    Johnson AD; Spero L
    Appl Environ Microbiol; 1981 Jun; 41(6):1479-81. PubMed ID: 6787986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the physiology of Bacillus anthracis Sterne during manufacture of the UK acellular anthrax vaccine.
    Charlton S; Herbert M; McGlashan J; King A; Jones P; West K; Roberts A; Silman N; Marks T; Hudson M; Hallis B
    J Appl Microbiol; 2007 Nov; 103(5):1453-60. PubMed ID: 17953556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of microwells to investigate the effect of quorum sensing on growth and antigen production in Bacillus anthracis Sterne 34F2.
    Mukhopadhyay TK; Allison N; Charlton S; Ward J; Lye GJ
    J Appl Microbiol; 2011 Nov; 111(5):1224-34. PubMed ID: 21895896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of spore surface antigens in the genus Bacillus by the use of polyclonal antibodies in immunofluorescence tests.
    Phillips AP; Martin KL
    J Appl Bacteriol; 1988 Jan; 64(1):47-55. PubMed ID: 3127370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on immunity in anthrax. IX. Effect of variations in cultural conditions on elaboration of protective antigen by strains of Bacillus anthracis.
    WRIGHT GG; PUZISS M; NEELY WB
    J Bacteriol; 1962 Mar; 83(3):515-22. PubMed ID: 14008433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-Generation Bacillus anthracis Live Attenuated Spore Vaccine Based on the htrA(-) (High Temperature Requirement A) Sterne Strain.
    Chitlaru T; Israeli M; Bar-Haim E; Elia U; Rotem S; Ehrlich S; Cohen O; Shafferman A
    Sci Rep; 2016 Jan; 6():18908. PubMed ID: 26732659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice.
    Welkos SL; Friedlander AM
    Microb Pathog; 1988 Aug; 5(2):127-39. PubMed ID: 3148815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and secretion of the protective antigen of Bacillus anthracis in Bacillus brevis.
    Rhie GE; Park YM; Chun JH; Yoo CK; Seong WK; Oh HB
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):331-9. PubMed ID: 16009541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
    Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of isogenic variants of Bacillus anthracis with various content of virulence plasmids].
    Barkova IA; Novozhenina AV; Barkov AM; Porokhnia SV; Tkachenko GA; Lipnitskiĭ AV
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (1):17-22. PubMed ID: 25842948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis.
    Farchaus JW; Ribot WJ; Jendrek S; Little SF
    Appl Environ Microbiol; 1998 Mar; 64(3):982-91. PubMed ID: 9501438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of the effect of linezolid and levofloxacin on Bacillus anthracis toxin production, spore formation and cell growth.
    Head BM; Alfa M; Sitar DS; Rubinstein E; Meyers AF
    J Antimicrob Chemother; 2017 Feb; 72(2):417-420. PubMed ID: 27798209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis.
    Welkos SL; Friedlander AM
    Microb Pathog; 1988 Jan; 4(1):53-69. PubMed ID: 3143893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncapsulated toxinogenic Bacillus anthracis presents a specific growth and dissemination pattern in naive and protective antigen-immune mice.
    Glomski IJ; Corre JP; Mock M; Goossens PL
    Infect Immun; 2007 Oct; 75(10):4754-61. PubMed ID: 17635863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of Bacillus anthracis mutant strains producing a single toxin component.
    Pezard C; Duflot E; Mock M
    J Gen Microbiol; 1993 Oct; 139(10):2459-63. PubMed ID: 8254316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Bacillus anthracis by polyclonal antibodies against extracted vegetative cell antigens.
    Phillips AP; Ezzell JW
    J Appl Bacteriol; 1989 May; 66(5):419-32. PubMed ID: 2502530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycerol monolaurate inhibits virulence factor production in Bacillus anthracis.
    Vetter SM; Schlievert PM
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1302-5. PubMed ID: 15793101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and purification of anthrax toxin.
    Leppla SH
    Methods Enzymol; 1988; 165():103-16. PubMed ID: 3148094
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant expression and purification of a tumor-targeted toxin in Bacillus anthracis.
    Bachran C; Abdelazim S; Fattah RJ; Liu S; Leppla SH
    Biochem Biophys Res Commun; 2013 Jan; 430(1):150-5. PubMed ID: 23200832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.